GNPX
Price
$1.79
Change
-$0.07 (-3.76%)
Updated
Dec 26 closing price
Capitalization
4.06M
Intraday BUY SELL Signals
TOVX
Price
$0.19
Change
-$0.00 (-0.00%)
Updated
Dec 26 closing price
Capitalization
6.45M
Intraday BUY SELL Signals
Interact to see
Advertisement

GNPX vs TOVX

Header iconGNPX vs TOVX Comparison
Open Charts GNPX vs TOVXBanner chart's image
Genprex
Price$1.79
Change-$0.07 (-3.76%)
Volume$120.2K
Capitalization4.06M
Theriva Biologics
Price$0.19
Change-$0.00 (-0.00%)
Volume$1.1M
Capitalization6.45M
GNPX vs TOVX Comparison Chart in %
GNPX
Daily Signal:
Gain/Loss:
TOVX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GNPX vs. TOVX commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNPX is a Hold and TOVX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (GNPX: $1.79 vs. TOVX: $0.19)
Brand notoriety: GNPX and TOVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNPX: 24% vs. TOVX: 7%
Market capitalization -- GNPX: $4.06M vs. TOVX: $6.45M
GNPX [@Biotechnology] is valued at $4.06M. TOVX’s [@Biotechnology] market capitalization is $6.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNPX’s FA Score shows that 0 FA rating(s) are green whileTOVX’s FA Score has 1 green FA rating(s).

  • GNPX’s FA Score: 0 green, 5 red.
  • TOVX’s FA Score: 1 green, 4 red.
According to our system of comparison, both GNPX and TOVX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNPX’s TA Score shows that 4 TA indicator(s) are bullish while TOVX’s TA Score has 4 bullish TA indicator(s).

  • GNPX’s TA Score: 4 bullish, 3 bearish.
  • TOVX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both GNPX and TOVX are a good buy in the short-term.

Price Growth

GNPX (@Biotechnology) experienced а -15.96% price change this week, while TOVX (@Biotechnology) price change was +0.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TOVX($6.45M) has a higher market cap than GNPX($4.06M). TOVX has higher P/E ratio than GNPX: TOVX (0.09) vs GNPX (0.09). TOVX YTD gains are higher at: -89.069 vs. GNPX (-95.796). GNPX has higher annual earnings (EBITDA): -16.38M vs. TOVX (-26.46M). TOVX has more cash in the bank: 7.53M vs. GNPX (1.1M). GNPX has less debt than TOVX: GNPX (279K) vs TOVX (2.76M). GNPX (0) and TOVX (0) have equivalent revenues.
GNPXTOVXGNPX / TOVX
Capitalization4.06M6.45M63%
EBITDA-16.38M-26.46M62%
Gain YTD-95.796-89.069108%
P/E Ratio0.090.0993%
Revenue00-
Total Cash1.1M7.53M15%
Total Debt279K2.76M10%
FUNDAMENTALS RATINGS
GNPX vs TOVX: Fundamental Ratings
GNPX
TOVX
OUTLOOK RATING
1..100
756
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9794
P/E GROWTH RATING
1..100
9875
SEASONALITY SCORE
1..100
n/a35

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TOVX's Valuation (12) in the null industry is in the same range as GNPX (37) in the Pharmaceuticals Major industry. This means that TOVX’s stock grew similarly to GNPX’s over the last 12 months.

TOVX's Profit vs Risk Rating (100) in the null industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that TOVX’s stock grew similarly to GNPX’s over the last 12 months.

TOVX's SMR Rating (99) in the null industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that TOVX’s stock grew similarly to GNPX’s over the last 12 months.

TOVX's Price Growth Rating (94) in the null industry is in the same range as GNPX (97) in the Pharmaceuticals Major industry. This means that TOVX’s stock grew similarly to GNPX’s over the last 12 months.

TOVX's P/E Growth Rating (75) in the null industry is in the same range as GNPX (98) in the Pharmaceuticals Major industry. This means that TOVX’s stock grew similarly to GNPX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNPXTOVX
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
78%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GNPX
Daily Signal:
Gain/Loss:
TOVX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLRX0.660.02
+3.35%
Salarius Pharmaceuticals Inc
KWR144.551.62
+1.13%
Quaker Houghton
SNCR8.520.05
+0.59%
Synchronoss Technologies
FLOC18.01-0.01
-0.06%
Flowco Holdings Inc
FNF54.89-0.09
-0.16%
Fidelity National Financial

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with NERV. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then NERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
-3.76%
NERV - GNPX
64%
Loosely correlated
+5.54%
TOVX - GNPX
49%
Loosely correlated
-1.70%
OMER - GNPX
48%
Loosely correlated
+2.28%
REVB - GNPX
48%
Loosely correlated
-1.14%
XERS - GNPX
31%
Poorly correlated
+2.22%
More

TOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TOVX has been loosely correlated with GOVX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TOVX jumps, then GOVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TOVX
1D Price
Change %
TOVX100%
-1.70%
GOVX - TOVX
54%
Loosely correlated
-0.39%
GNPX - TOVX
49%
Loosely correlated
-3.76%
VOR - TOVX
42%
Loosely correlated
+1.31%
TNXP - TOVX
35%
Loosely correlated
-3.13%
SER - TOVX
34%
Loosely correlated
+9.02%
More